Ignite Creation Date:
2024-05-06 @ 1:13 AM
Last Modification Date:
2024-10-26 @ 11:00 AM
Study NCT ID:
NCT01751035
Status:
COMPLETED
Last Update Posted:
2018-08-03
First Post:
2012-11-15
Brief Title:
Integrative Risk Reduction and Treatment for Teen Substance Use Problems and PTSD
Sponsor:
Medical University of South Carolina
Organization:
Medical University of South Carolina
Study Overview
Official Title:
Integrative Risk Reduction and Treatment for Teen Substance Use Problems and PTSD
Status:
COMPLETED
Status Verified Date:
2018-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RRFT
Brief Summary:
Adolescents receiving RRFT and their caregivers will report significantly fewer substance use problems quantity of use frequency of use and abuse symptoms during treatment and follow-up than control adolescents who receive Treatment as Usual TAU Adolescents receiving RRFT and their caregivers will report improvement in empirically-demonstrated risk and protective factors for substance use and abuse at the individual level eg coping and at each level of an adolescents ecology eg increased number of positive family activities reduced family conflict reduced number of peers who use drugs improved school attendance increased involvement in pro-social community activities during treatment and follow-up than control adolescents who receive TAU Adolescents receiving RRFT will experience less PTSD symptoms per youth and caregiver reports during treatment and follow-up than control adolescents who receive TAU Adolescents receiving RRFT will report engaging in fewer risky sexual behaviors eg increased condom use fewer partners during treatment and follow-up than control adolescents who receive TAU Changes during treatment in family relations familial cohesiveness and conflict satisfaction with caregiver-youth relationship and parenting practices monitoring will mediate changes in substance use Changes during treatment in emotional reactivity will mediate changes in PTSD symptoms
Detailed Description:
See above
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01DA031285-01 | NIH | None | httpsreporternihgovquickSearchR01DA031285-01 |